Cargando…
508. Biomarker elevation during COVID-19: Differences between ambulatory and hospitalized individuals
BACKGROUND: While the majority of illness due to COVID-19 does not require hospitalization, little has been described about the host inflammatory response in the ambulatory setting. Differences in the levels of inflammatory signaling proteins between outpatient and hospitalized populations could ide...
Autores principales: | Blair, Paul W, Lanteri, Charlotte, Striegel, Deborah, Agan, Brian, Maves, Ryan C, Chenoweth, Josh, Larson, Derek, Mende, Katrin, Colombo, Rhonda, Lindholm, David, Ganesan, Anuradha, Richard, Stephanie, Colombo, Chris, Madar, Cristian, Huprikar, Nikhil, Tribble, David, Dumler, John S, Burgess, Timothy, Clark, Danielle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778285/ http://dx.doi.org/10.1093/ofid/ofaa439.702 |
Ejemplares similares
-
337. SARS-CoV-2 Viral Load Does Not Predict Incident Venous Thromboembolism in COVID-19
por: Pollett, Simon, et al.
Publicado: (2021) -
34. Long-term clinical outcomes following SARS-CoV-2 infection include persistent symptoms and cardiovascular disease beyond 3 months post-infection
por: Richard, Stephanie A, et al.
Publicado: (2021) -
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19
por: Blair, Paul W., et al.
Publicado: (2022) -
458. A Machine Learning Approach Identifies Distinct Early-Symptom Cluster Phenotypes Which Correlate with Severe SARS-CoV-2 Outcomes
por: Epsi, Nusrat J, et al.
Publicado: (2021) -
1352. A Precision Medicine Approach to Predicting “Long COVID” through Machine Learning Analysis of Whole Blood Transcriptome Data
por: Epsi, Nusrat J, et al.
Publicado: (2023)